November 23, 2015 – The U.S. Food and Drug Administration has approved the sale of genetically modified salmon in the U.S.
“The FDA has approved AquaBounty Technologies’ application for AquAdvantage Salmon, an Atlantic salmon that reaches market size more quickly than non-GE farm-raised Atlantic salmon,” the agency said in a statement released November 19, 2015.
November 16, 2015 – The one-question ASAS JAM survey closed on the evening of Friday, November 13. More than 1,000 members voted, representing one of the largest responses to a survey in ASAS history.
- 59% voted NOT to have JAM at all costs
- 41% voted to have JAM, even with the understanding that ASAS would need to raise other charges to recoup shortfalls associated with JAM